Haematocrit and risk of development of Type 2 diabetes mellitus in middle-aged Japanese men

Diabetic Medicine

Volumn 21, Issue 5, 2004, Pages 476-482

  Nakanishi, N ^a   Suzuki, K ^b   Tatara, K ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Japan Labor and Welfare Association   (Japan)

Author keywords

Haematocrit; Incidence; Japanese men; Type 2 diabetes mellitus

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HEMATOCRIT; HUMAN; HYPOGLYCEMIA; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATIENT SELECTION; PREDICTION; RISK FACTOR; STRATIFICATION;

ADULT; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HEMATOCRIT; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 2342525843     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01152.x     Document Type: Article

References (37)

1. Moan A, Nordby G, Os I, Birkeland KI, Kjeldsen SE. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 1994; 43: 423-427.
2. Facchini FS, Carantoni M, Jeppesen J, Reaven GM. Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 1998; 47: 831-835.
3. Smith S, Julius S, Jamerson K, Amerena J, Schork N. Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. J Hypertens 1994; 12: 455-462.
4. Catalano C, Muscelli E, Natali A, Mazzoni A, Masoni A, Bernardini B et al. Reciprocal association between insulin sensitivity and the haematocrit in man. Eur J Clin Invest 1997; 27: 634-637.
5. Wannamethee SG, Perry IJ, Shaper AG. Hematocrit and risk of NIDDM. Diabetes 1996; 45: 576-579.
6. Nakanishi N, Yoshida H, Okamoto M, Nakamura K, Uzura S, Suzuki K et al. Hematocrit and risk for hypertension in middle-aged Japanese male office workers. Ind Health 2001; 39: 17-20.
7. Stolk RP, van Splunder IP, Schouten JS, Witteman JC, Hofman A, Grobbee DE. High blood pressure and the incidence of non-insulin dependent diabetes mellitus: findings in a 11.5 year follow-up study in the Netherlands. Eur J Epidemiol 1993; 9: 134-139.
8. Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes 1993; 42: 154-161.
9. Nakanishi N, Nakamura K, Marsuo Y, Suzuki K, Tatara K. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med 2000; 133: 183-191.
10. Ernst E. Haemorheological consequences of chronic cigarette smoking. J Cardiovasc Risk 1995; 2: 435-9.
11. Smith JR, Landaw SA. Smokers' polycythemia. N Engl J Med 1978; 298: 6-10.
12. Sagone AL Jr, Balcerzak SP. Smoking as a cause of erythrocytosis. Ann Intern Med 1975; 82: 512-515.
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
14. Nakanishi N, Yoshida H, Matsuo Y, Suzuki K, Tatara K. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia 2002; 45: 42-48.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
16. Cox DR. Regression models and life-tables. J Royal Statist Soc Series B, Methodological 1972; 34: 187-200.
17. Letcher RL, Chien S, Pickering TG, Laragh JH. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 1983; 5: 757-762.
18. Devereux RB, Drayer JI, Chien S, Pickering TG, Letcher RL, DeYoung JL et al. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 1984; 54: 592-595.
19. de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 1990; 81: 107-117.
20. Baron AD, Steinberg H, Brechtel G, Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 1994; 266: E248-E253.
21. Facchini FS, Stoohs RA, Reaven GM. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 1996; 9: 1013-1017.
22. Takaku F, Hirashima K, Okinaka S. Effect of bilateral section of the splanchnic nerve on erythropoiesis. Nature 1961; 191: 500-501.
23. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292.
24. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998; 18: 1199-1202.
25. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-1248.
26. Sim E. Humoral Factors. Oxford: IRL Press, 1993.
27. Facchini F, Hollenbeck CB, Chen YN, Chen YD, Reaven GM. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 1992; 232: 267-272.
28. Jeppesen JL, Maheux P, Facchini FS. White blood cell count and insulin resistance in healthy nonsmoking men. Am Heart J 1994; 127: 459-461.
29. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51: 455-461.
30. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254-260.
31. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150-1162.
32. Kissebah AH, Freedman DS, Peiris AN. Health risks of obesity. Med Clin North Am 1989; 73: 111-138.
33. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826-834.
34. Anderson JW, Gustafson NS, Bryart CA, Tietyen-Clark J. Dietary fiber and diabetes. J Am Diet Assoc 1987; 87: 1189-1197.
35. Mayer EJ, Newman B, Quesenberry CP Jr, Selby JV. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 1993; 16: 1459-1469.
36. Miller JC. Importance of glycemic index in diabetes. Am J Clin Nutr 1994; 59: 747S-752S.
37. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997; 277: 472-477.